Berlin, SANA- Leqembi, an approved drug for the treatment of Alzheimer’s disease, is expected to be officially launched in Germany on September 1st, following Austria’s launch on August 25th , , making them the first EU countries to have access to the therapy.
Austria and Germany are the first two countries in the European Union to launch the drug, which is marketed under the name of Leqembi, according to a statement issued by the Japanese pharmaceutical company, Eisai, and U.S. biotechnology Biogen Inc
This treatment, which was approved after much hesitation, could help a small amount of the approximately one million people with Alzheimer’s in Germany alone. Leqembi, is given intravenously every two weeks ,
Last April, the European Commission approved the drug of Leqembi,which treats early Alzheimer’s disease, specifically the stages of mild cognitive impairment (MCI) or mild dementia.
Noura / Mazen Eyon
Hence then, the article about leqembi treatment for alzheimer s disease is set to launch in germany was published today ( ) and is available on SANA ( Syria ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( (Leqembi) … Treatment for Alzheimer’s disease is set to launch in Germany )
Also on site :
- Monterey Bay Aquarium re-releases vintage otter tee worn by Taylor Swift to raise funds
- OpenAI pauses Sora video generations of Martin Luther King Jr.
- Source: Crews recover drowning victim from Canandaigua Lake